SEED News

SEED Therapeutics Nominated for 2026 Prix Galien USA “Best Start-Up” Award

Origin Agritech Secures Exclusive Nationwide Rights to Zhongdan 6202, the Flagship Machine-Harvest Corn Hybrid Developed Under China's National 14th Five-Year Plan Breeding Program

Origin Agritech Co-Authors Plant Biotechnology Journal Study That Breaks the Long-Standing Trade-Off Between Early-Maturing and High-Yield Corn

Origin Agritech Announces Financial Results for the First Half of Fiscal Year 2026

Genetically Modified Foods Market to Reach $451.60 Billion by 2030, Driven by Global Food Security Demands

SEED Therapeutics Reports Tumor Eradication in a Neuroblastoma In Vivo Model with Clinical-Stage RBM39 Molecular Glue Degrader ST-01156

Origin Agritech Launches Redesigned Corporate Website to Better Serve Partners, Customers, and Investors

Origin Agritech Names Global Crop Biotechnology Expert Dr. Jian Zhang to Board of Directors; Welcomes Return of Dr. Z. James Chen as Chief Financial Officer

Origin Agritech Launches "Aoyun 2026" New Variety Promotion Program to Drive Commercialization of Next-Generation Seed Varieties

Origin Agritech Announces Fiscal Year 2025 Results